Elaine Cadogan
10PUBLICATIONS
97CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Feb 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment.Elizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar
|Nov 20, 2023
Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue Sarcomas.Audrey Laroche-Clary, Coralie Josensi, Marie-Alix Derieppe
|Aug 14, 2023
Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing.Sandra Wimberger, Nina Akrap, Mike Firth
|Aug 03, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo
|May 26, 2022
A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models.Dharaminder Singh, Sudhir P Deosarkar, Elaine Cadogan
|Feb 12, 2022
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases.Alessia Anastasia, Giulia Dellavedova, Antonio Ramos-Montoya
Pageof 2
Frequent Collaborators
3 joint publications
Antonio Ramos-Montoya
2 joint publications
Alan Lau
2 joint publications
Adina Hughes
2 joint publications
Aaron Smith
1 joint publications
Sophie E Willis
1 joint publications
M Raymond V Finlay
1 joint publications
Simon T Barry
1 joint publications
Alessia Anastasia
1 joint publications
Giulia Dellavedova
1 joint publications
Massimo Russo
